Name: 6ix Investment Platform
Brand: 6ix

Latest Press Releases

Time	Headline
14m ago	Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
14m ago	Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
14m ago	Woodside Energy First Quarter Report for Period Ended 31 March 2026
15m ago	InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
42m ago	Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio

Nexalis Therapeutics Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Community Chat